1-[Bromo(chloro)methyl]-3-methylbenzene

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-[Bromo(chloro)methyl]-3-methylbenzene
• 英文别名: 1-[bromo(chloro)methyl]-3-methylbenzene
• 化学式: C₈H₈BrCl
• 分子量: 219.5
• InChiKey: DGGURIKZVAHEQU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

文献信息

• [EN] CATALYSTS<br/>[FR] CATALYSEURS
  申请人：BOREALIS AG

  公开号：WO2014096164A1

  公开（公告）日：2014-06-26

  An asymmetric complex of formula (I) wherein M is zirconium or hafnium; each X is a sigma ligand; L is a divalent bridge selected from -R'2C-, -R'2C-CR'2-, -R'2Si-, -R'2Si-SiR'2-, -R'2Ge-, wherein each R' is independently a hydrogen atom, C1-C20-alkyl, tri(C1-C20-alkyl)silyl, C6-C20-aryl, C7-C20-arylalkyl or C7-C20-alkylaryl; R2 and R2' are each independently a C1-C20 hydrocarbyl radical; R5' is a C1-20 hydrocarbyl group; R5 is hydrogen, or a C1-20 hydrocarbyl group; R6 is a non tertiary C1-10 alkyl group or C6-10-aryl group or C7-10 arylalkyl group or ZR3; R6' is a tertiary C4-20 alkyl group; Z is O or S; R3 is a C1-20 hydrocarbyl group optionally substituted with halo; Ar is an aryl or heteroaryl group having up to 20 carbon atoms optionally substituted by one or more groups R1; Ar' is an aryl or heteroaryl group having up to 20 carbon atoms optionally substituted by one or more groups R1; each R1 is a C1-20 hydrocarbyl group or two R1 groups on adjacent carbon atoms taken together can form a fused 5 or 6 membered ring with the Ar group, said ring being itself optionally substituted with one or more groups R4; and each R4 is a C1-20 hydrocarbyl group.

  一种公式(I)的不对称配合物，其中M为锆或铪；每个X为σ配体；L为从-R'2C-，-R'2C-CR'2-，-R'2Si-，-R'2Si-SiR'2-，-R'2Ge-中选择的二价桥，其中每个R'独立地为氢原子，C1-C20-烷基，三(C1-C20-烷基)硅基，C6-C20-芳基，C7-C20-芳基烷基或C7-C20-烷基芳基；R2和R2'各自独立为C1-C20烃基基团；R5'为C1-20烃基基团；R5为氢，或C1-20烃基基团；R6为非三级C1-10烷基基团或C6-10-芳基基团或C7-10芳基烷基基团或ZR3；R6'为三级C4-20烷基基团；Z为O或S；R3为C1-20烃基基团，可选择地被卤素取代；Ar为最多含有20个碳原子的芳基或杂芳基团，可选择地被一个或多个R1基团取代；Ar'为最多含有20个碳原子的芳基或杂芳基团，可选择地被一个或多个R1基团取代；每个R1为C1-20烃基基团，或相邻碳原子上的两个R1基团可以共同形成与Ar基团结合的融合的5或6元环，该环本身可选择地被一个或多个R4基团取代；每个R4为C1-20烃基基团。
• [EN] 4-{4-[(1 E)-4-(2,9-DIAZASPIRO[5.5]UNDEC-2-YL)BUT-1 -EN-1 -YL]-2-METHYLBENZYL}-5-(PROPAN-2-YL)-1 H-PYRAZOL-3-YL BETA-D- GLUCOPYRANOSIDE ACETATE<br/>[FR] ACÉTATE DE 4-{4-[(1E)-4-(2,9-DIAZASPIRO[5.5]UNDÉC-2-YL)BUT-1-ÉN-1-YL]-2-MÉTHYLBENZYL}-5-(PROPAN-2-YL)-1H-PYRAZOL-3-YL-BÊTA-D-GLUCOPYRANOSIDE
  申请人：LILLY CO ELI

  公开号：WO2015069541A1

  公开（公告）日：2015-05-14

  The present invention provides a compound of Formula I or hydrate thereof, useful for the treatment of diabetes.

  本发明提供了一种具有化学式I的化合物或其水合物，用于治疗糖尿病。
• PYRAZOLE COMPOUNDS AS SGLT1 INHIBITORS
  申请人：Eli Lilly and Company

  公开号：EP2850084A1

  公开（公告）日：2015-03-25
• 4-{4-[(1 E)-4-(2,9-DIAZASPIRO[5.5]UNDEC-2-YL)BUT-1 -EN-1 -YL]-2-METHYLBENZYL}-5-(PROPAN-2-YL)-1 H-PYRAZOL-3-YL BETA-D- GLUCOPYRANOSIDE ACETATE
  申请人：Eli Lilly and Company

  公开号：EP3066108A1

  公开（公告）日：2016-09-14
• [EN] PYRAZOLE COMPOUNDS AS SGLT1 INHIBITORS<br/>[FR] COMPOSÉS DE PYRAZOLE UTILISÉS EN TANT QU'INHIBITEURS DE SGLT1
  申请人：LILLY CO ELI

  公开号：WO2013169546A1

  公开（公告）日：2013-11-14

  The present invention provides a compound of Formula (II): wherein X represents the following: or a pharmaceutically acceptable salt thereof.